Recent Data on Adjuvant Therapies in HR+/HER2- Breast Cancer

Experts on HR+/HER2- breast cancer review data updates on adjuvant therapies from the 2023 ASCO Annual Meeting.

Related Keywords

Gregory Vidal ,Komal Jhaveri ,Aditya Bardia , ,